(For treatment side effects and complications only)
Cemiplimab Cutaneous Squamous Cell Carcinoma Protocol V1.0
Entrectinib - NTRK Gene Fusion-positive Solid Tumours ROS1-positive NSCLC Protocol V1.1
Larotrectinib NTRK Gene Fusion-positive Solid Tumours Protocol V1.0